---
title: "XENE SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Xenon Pharmaceuticals (XENE), with links to the SEC filings."
url: "https://tradytics.com/research/XENE/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=XENE&v=stock-11994868"
---

# XENE financial statements and SEC filings

## XENE annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $7.50M | -$373.07M | -$345.91M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2024-12-31 | $0.00 | -$279.30M | -$234.33M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2023-12-31 | $0.00 | -$214.05M | -$182.39M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2022-12-31 | $9.43M | -$129.14M | -$124.94M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017025029149/0000950170-25-029149-index.htm) |
| 2021-12-31 | $18.44M | -$78.99M | -$77.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017024023177/0000950170-24-023177-index.htm) |
| 2020-12-31 | $32.17M | -$31.30M | -$28.01M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017023005582/0000950170-23-005582-index.htm) |

## XENE annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $633.16M | $51.40M | $581.76M | [10-Q](https://www.sec.gov/Archives/edgar/data/1582313/000119312526453701/0001193125-26-453701-index.htm) |
| 2024-12-31 | $798.14M | $43.24M | $754.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2023-12-31 | $964.80M | $36.88M | $927.92M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017025029149/0000950170-25-029149-index.htm) |
| 2022-12-31 | $754.15M | $32.65M | $721.50M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017024023177/0000950170-24-023177-index.htm) |
| 2021-12-31 | $572.01M | $21.97M | $550.03M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017023005582/0000950170-23-005582-index.htm) |
| 2020-12-31 | $189.19M | $17.83M | $171.35M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000156459022008060/0001564590-22-008060-index.htm) |

## XENE annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$279.12M | -$799.00K | $117.11M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2024-12-31 | -$181.39M | -$3.08M | $12.13M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2023-12-31 | -$151.11M | -$5.62M | $353.52M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000119312526076650/0001193125-26-076650-index.htm) |
| 2022-12-31 | -$101.03M | -$2.89M | $278.47M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017025029149/0000950170-25-029149-index.htm) |
| 2021-12-31 | -$69.50M | -$2.05M | $447.54M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017024023177/0000950170-24-023177-index.htm) |
| 2020-12-31 | -$48.12M | -$2.64M | $85.80M | [10-K](https://www.sec.gov/Archives/edgar/data/1582313/000095017023005582/0000950170-23-005582-index.htm) |

- [XENE stock research](https://tradytics.com/research/XENE)
- [XENE financial summary](https://tradytics.com/research/XENE/financials)
- [Read the data without JavaScript](https://tradytics.com/research/XENE/fundamentals?snapshot=1)
